Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Medical Stocks To Watch Today - April 6th - Markets Daily
Eli Lilly and Company (NYSE:LLY) Stock Price Down 1% on Analyst Downgrade - Daily Political
Pharmaceutical Stocks To Watch Now - April 6th - Daily Political
Eli Lilly and Company $LLY is Aberdeen Group plc's 10th Largest Position
Eli Lilly and Company (NYSE:LLY) Stock Rating Lowered by Wall Street Zen
SWS Partners Makes New $2.39 Million Investment in Eli Lilly and Company $LLY
Herbst Group LLC Makes New Investment in Eli Lilly and Company $LLY
Banque Pictet & Cie SA Cuts Holdings in Eli Lilly and Company $LLY
Eli Lilly and Company $LLY Shares Sold by Bank Pictet & Cie Europe AG
Blue Trust Inc. Has $91.51 Million Stock Holdings in Eli Lilly and Company $LLY
Eli Lilly (LLY) Is Up 6.5% After FDA Clears Anytime Oral GLP-1 Foundayo for Obesity Treatment
Jim Cramer Likes Eli Lilly's (LLY) New Deal
Retireful LLC Invests $763,000 in Eli Lilly and Company $LLY
Frank Rimerman Advisors LLC Raises Stock Position in Eli Lilly and Company $LLY
PFG Private Wealth Management LLC Buys New Holdings in Eli Lilly and Company $LLY - Stock Observer
Eli Lilly and Company $LLY Shares Sold by Weatherly Asset Management L. P. - Daily Political
Eli Lilly and Company $LLY is Tema Etfs LLC's 4th Largest Position - Daily Political
Eli Lilly and Company $LLY is Gunderson Capital Management Inc.'s 6th Largest Position - Daily Political
Best Pharmaceutical Stocks To Follow Today - April 3rd - Markets Daily
Eli Lilly (LLY) Receives FDA Approval for Foundayo Weight Management Pill
11 Stocks in Focus: Jim Cramer on NVIDIA, Callers' Picks, and Recent AI Data Center Rally
Lilly's Foundayo New Weight Loss Pill To Be Available on TrumpRx With Lower GLP-1 Drug Prices
Moody Lynn & Lieberson LLC Purchases 2,657 Shares of Eli Lilly and Company $LLY
3,818 Shares in Eli Lilly and Company $LLY Acquired by Fulcrum Capital LLC
Nisa Investment Advisors LLC Raises Holdings in Eli Lilly and Company $LLY
Parkwoods Wealth Partners LLC Grows Stake in Eli Lilly and Company $LLY
Lilly's Foundayo enters oral GLP 1 market - BusinessToday
Target product profiles for treatments to delay or prevent symptomatic Alzheimer's disease
Eli Lilly and Company (NYSE:LLY) Shares Down 2% - Should You Sell?
Eli Lilly and Company (NYSE:LLY) Trading Up 3.6% - Here's What Happened
FDA Approves New GLP-1 Weight Loss Pill from Eli Lilly
How Eli Lilly's new GLP‑1 pill stacks up against Wegovy and other weight‑loss drugs
Eli Lilly and Company (NYSE:LLY) Trading Down 2% - Time to Sell? - Stock Observer
FDA approves once-daily GLP-1 weight loss pill with 'greater flexibility' | Fox News
Medical Stocks To Research - April 2nd - Stock Observer
Is Eli Lilly and Company (LLY) The Best Pharma Stock to Invest In Now?
Bank of America Increases Eli Lilly and Company (NYSE:LLY) Price Target to $1,294.00
Novo says Wegovy pill outperforms Lilly's oral GLP-1
Eli Lilly and Company $LLY Shares Sold by Vaughan Nelson Investment Management L.P. - Markets Daily
Best Pharmaceutical Stocks To Follow Now - April 2nd - Daily Political
MOR Wealth Management LLC Acquires New Shares in Eli Lilly and Company $LLY
J. Safra Sarasin Holding AG Boosts Holdings in Eli Lilly and Company $LLY
Northstar Advisory Group LLC Buys 2,565 Shares of Eli Lilly and Company $LLY - Stock Observer
She Lost 100 Pounds on Zepbound. Then Her Insurance Cut Her Off - Business Insider
Eli Lilly and Company $LLY Stock Holdings Lowered by Brookstone Capital Management
Guggenheim Cuts Eli Lilly and Company (NYSE:LLY) Price Target to $1,163.00 - Markets Daily
Eli Lilly and Company $LLY Shares Sold by Boston Common Asset Management LLC
FDA Approves Lilly's Weight-Loss Pill, Igniting Clash With Novo Nordisk
Eli Lilly and Company $LLY Shares Purchased by Allspring Global Investments Holdings LLC
Eli Lilly and Company $LLY is Mn Services Vermogensbeheer B.V.'s 9th Largest Position - Stock Observer
Bank of America Forecasts Strong Price Appreciation for Eli Lilly and Company (NYSE:LLY) Stock - Daily Political
Retirement Systems of Alabama Sells 655 Shares of Eli Lilly and Company $LLY - Daily Political
Private Advisory Group LLC Trims Stock Position in Eli Lilly and Company $LLY - Daily Political
Stock market today: Dow, S&P 500, Nasdaq extend rally for 2nd day on hopes of Iran war deescalation
FDA approves Lilly's Foundayo, first unrestricted GLP-1 pill
Eli Lilly stock pops after FDA approves new GLP-1 weight-loss pill
FDA approves Eli Lilly's Foundayo pill for weight loss
Eli Lilly weight loss pill Foundayo approved by FDA, shares rise
FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions | Morningstar
Traders Buy High Volume of Eli Lilly and Company Call Options (NYSE:LLY) - Daily Political
These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target
Gemcitabine Hydrochloride Market Report 2026-2030 & 2035 Featuring Strategic Analysis of Fresenius Kabi, Eli Lilly and Company, Teva Pharma, Intas Pharma, Mylan and More
Eli Lilly and Company $LLY Shares Sold by Goelzer Investment Management Inc.
Centessa (CNTA) Soars to All-Time High on 38% Upside from Eli Lilly Merger
Lilly's Foundayo enters oral GLP-1 obesity market with speedy FDA nod | BioWorld
Goelzer Investment Management Inc. Cuts Stock Position in Eli Lilly and Company $LLY - Daily Political
Nxera Pharma's Partner Centessa Pharmaceuticals to be Acquired by Lilly
Pharmaceutical Stocks To Watch Today - March 31st
Centessa Pharmaceuticals Stock Soars 45% Over Acquisition Deal With Eli Lilly And Company
Eli Lilly Is Bringing AI-Developed Drugs to Market. Should You Buy LLY Stock to Profit?
Chesley Taft & Associates LLC Buys 1,518 Shares of Eli Lilly and Company $LLY
Eli Lilly and Company $LLY Shares Acquired by Worth Asset Management LLC - Stock Observer
Vanda's tradipitant has phase II success but a court setback | BioWorld
Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy | BioWorld
A deep joint-learning proteomics model for diagnosis of six conditions associated with dementia
Eli Lilly and Company (NYSE:LLY) Price Target Lowered to $1,163.00 at Guggenheim
Eli Lilly and Company (LLY) Continued to Gain from Its Incretin Portfolio
5 Things to Know Before the Stock Market Opens
Eli Lilly's (LLY) Shares Up Since Jim Cramer Said He Was a Long Term Believer
Neuroblastoma Market Analysis Report 2026-2030 | Rising Childhood Cancer Incidence Fuels Demand | Identify Lucrative Growth Segments for Investment Purposes
Eli Lilly and Company $LLY Stake Boosted by Matrix Trust Co
Mather Group LLC. Purchases 2,250 Shares of Eli Lilly and Company $LLY
Trending tickers: Exxon Mobil, Eli Lilly, Rio Tinto and Boohoo
Eli Lilly and Company $LLY Shares Acquired by Exchange Traded Concepts LLC
Dakota Wealth Management Reduces Holdings in Eli Lilly and Company $LLY
Guggenheim Lowers Eli Lilly and Company (NYSE:LLY) Price Target to $1,163.00 - Daily Political
Lilly taps Insilico AI in $2.75B deal to expand pipeline options | BioWorld
Eli Lilly seeks higher NHS drug prices, rebate overhaul to restart UK investment, FT reports - Yahoo News Canada
Insilico Medicine partners with Lilly on drug discovery collaboration
